BGF invested in Intrapharm in August 2014 and supported the company's acquisition of three specialist pharma companies: Peckforton Pharmaceuticals, Alvedon, Aquamax.
Following a period of sustained growth, with revenues increasing from £4m to £12m during BGF’s investment, the business was acquired by German pharmaceutical company RIEMSER Pharma GmbH in November 2015 with all shareholders realising a strong return.
Business funding insights
A decade of hard work coming to fruition? Just look at our investments and exits
Far from slowing down as a result of the coronavirus pandemic, BGF’s investment activity has stepped up both in pace and volume.
Exit strategies: how to get the timing and valuation right
More than 100 BGF-backed businesses have achieved exits. Our panel of experts discuss the exit strategies that are proven to succeed.